Vanda Pharmaceuticals
VNDA
#7647
Rank
NZ$0.49 B
Marketcap
$8.45
Share price
3.24%
Change (1 day)
33.95%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2024 (TTM): -NZ$60.68 Million

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.19 Billion. In 2023 the company made an earning of -NZ$24.66 Million a decrease over its 2022 earnings that were of NZ$11.18 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$60.68 Million146.07%
2023 -NZ$24.66 Million-320.45%
2022 NZ$11.18 M-84.99%
2021 NZ$74.51 M54.8%
2020 NZ$48.13 M19.42%
2019 NZ$40.31 M4.93%
2018 NZ$38.41 M-228.6%
2017 -NZ$29.88 Million-8.98%
2016 -NZ$32.83 Million-53.79%
2015 -NZ$71.02 Million-30.18%
2014 -NZ$0.11 Billion173.08%
2013 -NZ$37.25 Million-25.33%
2012 -NZ$49.89 Million163.61%
2011 -NZ$18.93 Million-221.15%
2010 NZ$15.61 M-124.53%
2009 -NZ$63.68 Million-29.44%
2008 -NZ$90.25 Million-36.2%
2007 -NZ$0.15 Billion21.81%
2006 -NZ$0.12 Billion170.55%
2005 -NZ$42.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$22.50 B-34,074.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$17.93 B-27,186.06%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$32.50 B-49,186.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$12.16 Billion 18,258.91%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$12.27 B-18,627.02%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$9.66 Million-85.43%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$26.46 B-40,054.64%๐Ÿ‡บ๐Ÿ‡ธ USA